(Q38881215)

English

Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis

scientific article published on February 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

0 references

Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis (English)

1 reference

Europe PubMed Central

7 September 2017

0 references

1 reference

based on heuristic

inferred from title

latent tuberculosis

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

author name string

Javier Ena

1

1 reference

Europe PubMed Central

7 September 2017

Victoria Valls

2

1 reference

Europe PubMed Central

7 September 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

7 September 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

7 September 2017

40

1 reference

Europe PubMed Central

7 September 2017

5

1 reference

Europe PubMed Central

7 September 2017

670-676

1 reference

Europe PubMed Central

7 September 2017

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1086%2F427802

21 January 2018

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit

1 reference

https://api.crossref.org/works/10.1086%2F427802

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1086%2F427802

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1086%2F427802

21 January 2018

Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis

1 reference

https://api.crossref.org/works/10.1086%2F427802

21 January 2018

[Evaluation of 2 tuberculosis chemoprophylaxis regimens in patients infected with human immunodeficiency virus. The GECMEI Group]

1 reference

https://api.crossref.org/works/10.1086%2F427802

21 January 2018

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

1 reference

https://api.crossref.org/works/10.1086%2F427802

21 January 2018

Isoniazid prophylaxis for tuberculosis in HIV infection: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1086%2F427802

21 January 2018

Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals

1 reference

https://api.crossref.org/works/10.1086%2F427802

21 January 2018

Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998

1 reference

https://api.crossref.org/works/10.1086%2F427802

21 January 2018

Identifiers

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38881215&oldid=2143373246"